Abstract
Guillain-Barré syndrome (GBS) has been reported as one of the neurological manifestations linked to COVID-19, a severe acute respiratory syndrome caused by coronavirus 2. We present the case of a 72-year-old male patient attending a tertiary care hospital in Muscat, Oman, in 2020 with a history of progressive bilateral limb weakness and numbness. The current diagnosis was in line with a rare complication of COVID-19. After exclusion of other possible causes, a diagnosis of GBS induced by COVID-19 was made. The patient received 0.4g/kg of intravenous immunoglobulin (IVIG) per day for five days. This case report highlights the characteristics and course of GBS following COVID-19 infection. Further studies are needed to characterize the manifestations and course of various neuromuscular disorders in relation to COVID-19 infection.
Keywords: COVID-19; Guillain-Barré syndrome; IVIG; Oman.
【저자키워드】 COVID-19, IVIG, Guillain-barrè syndrome, Oman, 【초록키워드】 Intravenous immunoglobulin, coronavirus, hospital, Diagnosis, Case report, Characteristics, COVID-19 infection, male, Patient, Care, manifestation, Oman, acute respiratory syndrome, causes, syndrome, weakness, exclusion, disorder, complication of COVID-19, neurological manifestation, FIVE, highlight, limb, Course, caused, reported, per day, Muscat, 【제목키워드】 Case report, Oman,